Cited by 29Molecular Sensors and Ion DetectionLuminescence and Fluorescent MaterialsNanoplatforms for cancer theranostics

Refashioning benzothiadiazole dye as an activatable nanoprobe for biomarker detection with NIR-II fluorescence/optoacoustic imaging

Open access
Chen, Junjie, Chen, Longqi, Fang, Yichang, Zeng, Fang, Wu, Shuizhu·2022·Cell Reports Physical Science

Abstract

Endogenous nitric oxide is important for living beings; hence, accurate and non-invasive detection of nitric oxide (NO) in situ is of significance. Benzothiadiazole-core chromophores are important near-infrared II (NIR-II) dyes, but such limitations as fluorescence quenching in aqueous media and non-activatable response constitute major barriers for biological applications. To address these issues, here we report an activatable nanoprobe, [email protected]βCD, with aggregation-induced emission for detecting the biomarker NO. The molecular probe BNDA and 2-hydroxypropyl-β-cyclodextrin (HβCD) form the amphiphilic host-guest complex BNDA-HβCD, which readily forms nanoaggregates in aqueous media and thereby affords the nanoprobe [email protected]βCD. NO reacts with the probe and generates the activated probe, which displays strong NIR-II fluorescence emission and optoacoustic signals. [email protected]βCD can detect liver injury and monitor therapeutic outcome in a mouse model by detecting hepatic NO; it can also image NO in soybean sprouts. The results indicate that [email protected]βCD is a robust tool for detecting NO in both animals and plants.

Integrity signals

Registry

Crossref · 10.1016/j.xcrp.2021.100570

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Upon reaction with NO, the phenylenediamino group was converted into a triazole, markedly enhancing the electron-withdrawing strength of the BTD core and activating strong NIR-II fluorescence at 900-1100 nm and optoacoustic absorption at 650-850 nm.

    “Upon reaction with NO, the phenylenediamino group was converted into a triazole, markedly enhancing the electron-withdrawing strength of the BTD core and activating strong NIR-II fluorescence (900–1100 nm) and optoacoustic absorption (650–850 nm).”
  • Wu et al. reported an activatable molecular probe featuring an ortho-phenylenediamino moiety as a specific NO-responsive unit attached to the benzothiadiazole core.

    “Wu et al. reported an activatable molecular probe, featuring an ortho-phenylenediamino moiety as a specific NO-responsive unit attached to the benzothiadiazole (BTD) core124.”

The citation lists haven’t been fetched yet

References 72 · Cited by 29

Authors
Chen, J., Chen, L., Fang, Y., Zeng, F., & Wu, S.
Affiliations
State Key Laboratory of Luminescent Materials and Devices (CN)
Corresponding author
  • Zeng, Fang
  • Wu, Shuizhu
Venue
Cell Reports Physical Science
Publisher
Elsevier BV
Published
2022-02
Volume
3
Issue
2
Pages
100570
ISSN
2666-3864 (ISSN-L)
OpenAlex
W3200238379
Cited by
29
References
72
Citations by year
2026: 4 · 2025: 8 · 2024: 3 · 2023: 5 · 2022: 9
FWCI
1.55
Type
journal article
Language
en
Open access
Locations
  • Cell Reports Physical Science (publishedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (21788102, 21875069)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Molecular Sensors and Ion Detection
  • Physical Sciences › Materials Science › Materials Chemistry › Luminescence and Fluorescent Materials
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
nitric oxide detection, NIR-II fluorescence, photoacoustic imaging, aggregation-induced emission, host-guest complexes, hydroxypropyl-β-cyclodextrin, nanoparticle aggregation, biomarker detection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review